GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL
C/ Severo Ochoa Numero 2 Parque Tecnologico De Mad – Tres Cantos Madrid – 28760
VAT: ESB83326389
http://www.gsk.es/html/investigacion/espana.html
Complicit EU Projects
GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL did not participate in Horizon 2020 (2014-2020).
Within the Horizon Europe (2021-2027) framework, GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL has received € 760,000.0 for its participation in a total of 1 project(s) with a total cost of € 4,686,951.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-01 | 101080462 | ITHEMYC | primatology · tuberculosis · vaccines · immunotherapy · antibiotic resistance | 2027-05-31 | participant | € 760,000.0 | € 4,686,951 | 1 | 11 | CORDIS ↪ |
Within the FP7 (2007-2013) framework, GLAXOSMITHKLINE INVESTIGACION Y DESARROLLO SL has received € 256,410.0 for its participation in a total of 1 project(s) with a total cost of € 3,307,409.
| Start (YYYYMMDD) | Project ID | Project Name | Themes | End (YYYYMMDD) | Role | EC Contribution | Total Cost | IL Participation | Total Participation | CORDIS Link |
|---|---|---|---|---|---|---|---|---|---|---|
| 2011-11-01 | 290257 | UPSTREAM | drug discovery · proteins | 2015-10-31 | participant | € 256,410.0 | € 3,307,409 | 1 | 10 | CORDIS ↪ |